{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:29:46Z","timestamp":1792024186703,"version":"4.4.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"DOI":"10.1007\/s10557-026-07950-y","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:29:28Z","timestamp":1788589768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spatiotemporal Nanotherapy After Myocardial Infarction: Targeting the Inflammatory-to-reparative Transition With Extracellular Vesicles and Engineered Nanoparticles"],"prefix":"10.1007","author":[{"given":"Xuesi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"7950_CR1","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1006\/jmcc.1998.0829","volume":"30","author":"NG Frangogiannis","year":"1998","unstructured":"Frangogiannis NG, Youker KA, Rossen RD, et al. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol. 1998;30:2567\u201376. https:\/\/doi.org\/10.1006\/jmcc.1998.0829.","journal-title":"J Mol Cell Cardiol"},{"key":"7950_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1172\/JCI117680","volume":"95","author":"GL Kukielka","year":"1995","unstructured":"Kukielka GL, Smith CW, LaRosa GJ, et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest. 1995;95:89\u2013103. https:\/\/doi.org\/10.1172\/JCI117680.","journal-title":"J Clin Invest"},{"key":"7950_CR3","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1161\/01.CIR.92.7.1866","volume":"92","author":"GL Kukielka","year":"1995","unstructured":"Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardium: potential role in postreperfusion inflammatory injury. Circulation. 1995;92:1866\u201375. https:\/\/doi.org\/10.1161\/01.CIR.92.7.1866.","journal-title":"Circulation"},{"key":"7950_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/01.RES.0000163017.13772.3A","volume":"96","author":"O Dewald","year":"2005","unstructured":"Dewald O, Zymek P, Winkelmann K, et al. CCL2\/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res. 2005;96:881\u20139. https:\/\/doi.org\/10.1161\/01.RES.0000163017.13772.3A.","journal-title":"Circ Res"},{"key":"7950_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/eurheartj\/ehw002","volume":"38","author":"M Horckmans","year":"2017","unstructured":"Horckmans M, Ring L, Duchene J, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J. 2017;38:187\u201397. https:\/\/doi.org\/10.1093\/eurheartj\/ehw002.","journal-title":"Eur Heart J"},{"key":"7950_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2015.03.054","volume":"185","author":"RP Iyer","year":"2015","unstructured":"Iyer RP, Patterson NL, Zouein FA, et al. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution. Int J Cardiol. 2015;185:198\u2013208. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.054.","journal-title":"Int J Cardiol"},{"key":"7950_CR7","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1084\/jem.20070885","volume":"204","author":"M Nahrendorf","year":"2007","unstructured":"Nahrendorf M, Swirski FK, Aikawa E, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204:3037\u201347. https:\/\/doi.org\/10.1084\/jem.20070885.","journal-title":"J Exp Med"},{"key":"7950_CR8","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1161\/CIRCRESAHA.114.303204","volume":"114","author":"I Hilgendorf","year":"2014","unstructured":"Hilgendorf I, Gerhardt LMS, Tan TC, et al. Ly-6\u00a0C-high monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res. 2014;114:1611\u201322. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.303204.","journal-title":"Circ Res"},{"key":"7950_CR9","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"H Khalil","year":"2017","unstructured":"Khalil H, Kanisicak O, Prasad V, et al. Fibroblast-specific TGF-beta-SMAD2\/3 signaling underlies cardiac fibrosis. J Clin Invest. 2017;127:3770\u201383. https:\/\/doi.org\/10.1172\/JCI94753.","journal-title":"J Clin Invest"},{"key":"7950_CR10","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10557-023-07472-x","volume":"38","author":"H Wu","year":"2024","unstructured":"Wu H, Qian X, Liang G. The role of small extracellular vesicles derived from mesenchymal stromal cells on myocardial protection: a review of current advances and future perspectives. Cardiovasc Drugs Ther. 2024;38:1111\u201322. https:\/\/doi.org\/10.1007\/s10557-023-07472-x.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7950_CR11","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s10557-025-07828-5","volume":"40","author":"R Sanwlani","year":"2026","unstructured":"Sanwlani R, Camelliti P. Extracellular vesicles in cardiac cell crosstalk: from intercellular communication to clinical translation. Cardiovasc Drugs Ther. 2026;40:1553\u201374. https:\/\/doi.org\/10.1007\/s10557-025-07828-5.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7950_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10557-024-07557-1","volume":"39","author":"KY Chen","year":"2025","unstructured":"Chen KY, Liu Z, Lu JH, Yang SY, Hu XY, Liang GY. The function of circular RNAs in myocardial ischemia\u2013reperfusion injury: underlying mechanisms and therapeutic advancement. Cardiovasc Drugs Ther. 2025;39:875\u201386. https:\/\/doi.org\/10.1007\/s10557-024-07557-1.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7950_CR13","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10557-025-07824-9","volume":"40","author":"X Feng","year":"2026","unstructured":"Feng X, Wang D, Xu C. Lipid-mediated exosomal signaling modulates G6PD-dependent metabolic remodeling in heart failure. Cardiovasc Drugs Ther. 2026;40:1233\u20134. https:\/\/doi.org\/10.1007\/s10557-025-07824-9.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7950_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10557-025-07792-0","volume":"40","author":"C Dang","year":"2026","unstructured":"Dang C, Quinn CJ, Wehrens XHT. \u201cBig things come in small packages\u201d: are bone marrow mesenchymal stem cell-derived extracellular vesicles a useful therapeutic tool for heart failure. Cardiovasc Drugs Ther. 2026;40:419\u201322. https:\/\/doi.org\/10.1007\/s10557-025-07792-0.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7950_CR15","doi-asserted-by":"publisher","first-page":"H692","DOI":"10.1152\/ajpheart.00634.2005","volume":"290","author":"Y Xu","year":"2006","unstructured":"Xu Y, Huo Y, Toufektsian MC, et al. Activated platelets contribute importantly to myocardial reperfusion injury. Am J Physiol Heart Circ Physiol. 2006;290:H692\u20139. https:\/\/doi.org\/10.1152\/ajpheart.00634.2005.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7950_CR16","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.110.014555","volume":"123","author":"D Kohler","year":"2011","unstructured":"Kohler D, Straub A, Weissmuller T, et al. Phosphorylation of vasodilator-stimulated phosphoprotein prevents platelet-neutrophil complex formation and dampens myocardial ischemia-reperfusion injury. Circulation. 2011;123:2579\u201390. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.014555.","journal-title":"Circulation"},{"key":"7950_CR17","doi-asserted-by":"publisher","first-page":"H500","DOI":"10.1152\/ajpheart.00381.2014","volume":"308","author":"L Ge","year":"2015","unstructured":"Ge L, Zhou X, Ji WJ, et al. Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy. Am J Physiol Heart Circ Physiol. 2015;308:H500\u20139. https:\/\/doi.org\/10.1152\/ajpheart.00381.2014.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7950_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1182\/blood-2013-07-514992","volume":"123","author":"AS Savchenko","year":"2014","unstructured":"Savchenko AS, Borissoff JI, Martinod K, et al. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia\/reperfusion injury in mice. Blood. 2014;123:141\u20138. https:\/\/doi.org\/10.1182\/blood-2013-07-514992.","journal-title":"Blood"},{"key":"7950_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52671-y","volume":"9","author":"A Mangold","year":"2019","unstructured":"Mangold A, Hofbauer TM, Ondracek AS, et al. Neutrophil extracellular traps and monocyte subsets at the culprit lesion site of myocardial infarction patients. Sci Rep. 2019;9:16304. https:\/\/doi.org\/10.1038\/s41598-019-52671-y.","journal-title":"Sci Rep"},{"key":"7950_CR20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325:612\u20136. https:\/\/doi.org\/10.1126\/science.1175202.","journal-title":"Science"},{"key":"7950_CR21","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.112.000116","volume":"127","author":"MD Majmudar","year":"2013","unstructured":"Majmudar MD, Keliher EJ, Heidt T, et al. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation. 2013;127:2038\u201346. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.000116.","journal-title":"Circulation"},{"key":"7950_CR22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/nm.3284","volume":"19","author":"Y Zouggari","year":"2013","unstructured":"Zouggari Y, Ait-Oufella H, Bonnin P, et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med. 2013;19:1273\u201380. https:\/\/doi.org\/10.1038\/nm.3284.","journal-title":"Nat Med"},{"key":"7950_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.immuni.2013.11.019","volume":"40","author":"S Epelman","year":"2014","unstructured":"Epelman S, Lavine KJ, Beaudin AE, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity. 2014;40:91\u2013104. https:\/\/doi.org\/10.1016\/j.immuni.2013.11.019.","journal-title":"Immunity"},{"key":"7950_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","volume":"20","author":"SA Dick","year":"2019","unstructured":"Dick SA, Macklin JA, Nejat S, et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat Immunol. 2019;20:29\u201339. https:\/\/doi.org\/10.1038\/s41590-018-0272-2.","journal-title":"Nat Immunol"},{"key":"7950_CR25","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1172\/JCI85782","volume":"126","author":"M Shiraishi","year":"2016","unstructured":"Shiraishi M, Shintani Y, Shintani Y, et al. Alternatively activated macrophages determine repair of the infarcted adult murine heart. J Clin Invest. 2016;126:2151\u201366. https:\/\/doi.org\/10.1172\/JCI85782.","journal-title":"J Clin Invest"},{"key":"7950_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/cvr\/cvw024","volume":"110","author":"Y Ma","year":"2016","unstructured":"Ma Y, Yabluchanskiy A, Iyer RP, et al. Temporal neutrophil polarization following myocardial infarction. Cardiovasc Res. 2016;110:51\u201361. https:\/\/doi.org\/10.1093\/cvr\/cvw024.","journal-title":"Cardiovasc Res"},{"key":"7950_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yjmcc.2020.06.006","volume":"145","author":"MJ Daseke II","year":"2020","unstructured":"Daseke MJ II, Tenkorang-Impraim MAA, Ma Y, et al. Exogenous IL-4 shuts off pro-inflammation in neutrophils while stimulating anti-inflammation in macrophages to induce neutrophil phagocytosis following myocardial infarction. J Mol Cell Cardiol. 2020;145:112\u201321. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.06.006.","journal-title":"J Mol Cell Cardiol"},{"key":"7950_CR28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41419-018-0710-y","volume":"9","author":"JA Marwick","year":"2018","unstructured":"Marwick JA, Mills R, Kay O, et al. Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-kappaB activation. Cell Death Dis. 2018;9:665. https:\/\/doi.org\/10.1038\/s41419-018-0710-y.","journal-title":"Cell Death Dis"},{"key":"7950_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bioactmat.2021.08.008","volume":"9","author":"L Bao","year":"2022","unstructured":"Bao L, Dou G, Tian R, et al. Engineered neutrophil apoptotic bodies ameliorate myocardial infarction by promoting macrophage efferocytosis and inflammation resolution. Bioact Mater. 2022;9:183\u201397. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.08.008.","journal-title":"Bioact Mater"},{"key":"7950_CR30","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.4049\/jimmunol.165.5.2798","volume":"165","author":"NG Frangogiannis","year":"2000","unstructured":"Frangogiannis NG, Mendoza LH, Lindsey ML, et al. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol. 2000;165:2798\u2013808. https:\/\/doi.org\/10.4049\/jimmunol.165.5.2798.","journal-title":"J Immunol"},{"key":"7950_CR31","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.121.057549","volume":"145","author":"D Jia","year":"2022","unstructured":"Jia D, Chen S, Bai P, et al. Cardiac resident macrophage-derived legumain improves cardiac repair by promoting clearance and degradation of apoptotic cardiomyocytes after myocardial infarction. Circulation. 2022;145:1542\u201356. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057549.","journal-title":"Circulation"},{"key":"7950_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","volume":"115","author":"J Weirather","year":"2014","unstructured":"Weirather J, Hofmann UDW, Beyersdorf N, et al. FOXP3-positive CD4-positive T cells improve healing after myocardial infarction by modulating monocyte\/macrophage differentiation. Circ Res. 2014;115:55\u201367. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.303895.","journal-title":"Circ Res"},{"key":"7950_CR33","doi-asserted-by":"publisher","first-page":"H1233","DOI":"10.1152\/ajpheart.00328.2014","volume":"307","author":"A Saxena","year":"2014","unstructured":"Saxena A, Dobaczewski M, Rai V, et al. Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function. Am J Physiol Heart Circ Physiol. 2014;307:H1233\u201342. https:\/\/doi.org\/10.1152\/ajpheart.00328.2014.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7950_CR34","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1161\/CIRCULATIONAHA.111.044164","volume":"125","author":"U Hofmann","year":"2012","unstructured":"Hofmann U, Beyersdorf N, Weirather J, et al. Activation of CD4-positive T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation. 2012;125:1652\u201363. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.044164.","journal-title":"Circulation"},{"key":"7950_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07328-z","volume":"7","author":"Y Shintani","year":"2017","unstructured":"Shintani Y, Ito T, Fields L, et al. IL-4 as a repurposed biological drug for myocardial infarction through augmentation of reparative cardiac macrophages: proof-of-concept data in mice. Sci Rep. 2017;7:6877. https:\/\/doi.org\/10.1038\/s41598-017-07328-z.","journal-title":"Sci Rep"},{"key":"7950_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-017-0622-5","volume":"112","author":"M Jung","year":"2017","unstructured":"Jung M, Ma Y, Iyer RP, et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol. 2017;112:33. https:\/\/doi.org\/10.1007\/s00395-017-0622-5.","journal-title":"Basic Res Cardiol"},{"key":"7950_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04908-z","volume":"9","author":"S Zacchigna","year":"2018","unstructured":"Zacchigna S, Martinelli V, Moimas S, et al. Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction. Nat Commun. 2018;9:2432. https:\/\/doi.org\/10.1038\/s41467-018-04908-z.","journal-title":"Nat Commun"},{"key":"7950_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-019-0715-4","volume":"114","author":"AJ Mouton","year":"2019","unstructured":"Mouton AJ, Ma Y, Rivera Gonzalez OJ, et al. Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis. Basic Res Cardiol. 2019;114:6. https:\/\/doi.org\/10.1007\/s00395-019-0715-4.","journal-title":"Basic Res Cardiol"},{"key":"7950_CR39","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.3390\/ijms21103685","volume":"21","author":"A Curaj","year":"2020","unstructured":"Curaj A, Schumacher D, Rusu M, et al. Neutrophils modulate fibroblast function and promote healing and scar formation after murine myocardial infarction. Int J Mol Sci. 2020;21:3685. https:\/\/doi.org\/10.3390\/ijms21103685.","journal-title":"Int J Mol Sci"},{"key":"7950_CR40","doi-asserted-by":"publisher","first-page":"e004408","DOI":"10.1161\/JAHA.112.004408","volume":"1","author":"X Yan","year":"2012","unstructured":"Yan X, Shichita T, Katsumata Y, et al. Deleterious effect of the IL-23\/IL-17A axis and gamma-delta T cells on left ventricular remodeling after myocardial infarction. J Am Heart Assoc. 2012;1:e004408. https:\/\/doi.org\/10.1161\/JAHA.112.004408.","journal-title":"J Am Heart Assoc"},{"key":"7950_CR41","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1096\/fj.201700109R","volume":"31","author":"B Tourki","year":"2017","unstructured":"Tourki B, Halade GV. Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling. FASEB J. 2017;31:4226\u201339. https:\/\/doi.org\/10.1096\/fj.201700109R.","journal-title":"FASEB J"},{"key":"7950_CR42","doi-asserted-by":"publisher","first-page":"H269","DOI":"10.1152\/ajpheart.00604.2014","volume":"308","author":"EF Lopez","year":"2015","unstructured":"Lopez EF, Kabarowski JH, Ingle KA, et al. Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction. Am J Physiol Heart Circ Physiol. 2015;308:H269\u201380. https:\/\/doi.org\/10.1152\/ajpheart.00604.2014.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7950_CR43","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/cvr\/cvae142","volume":"120","author":"TTJ Kufazvinei","year":"2024","unstructured":"Kufazvinei TTJ, Chai J, Boden KA, Channon KM, Choudhury RP. Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes. Cardiovasc Res. 2024;120:1241\u201352. https:\/\/doi.org\/10.1093\/cvr\/cvae142.","journal-title":"Cardiovasc Res"},{"key":"7950_CR44","doi-asserted-by":"publisher","first-page":"e015672","DOI":"10.1161\/JAHA.119.015672","volume":"9","author":"AB Pullen","year":"2020","unstructured":"Pullen AB, Kain V, Serhan CN, Halade GV. Molecular and cellular differences in cardiac repair of male and female mice. J Am Heart Assoc. 2020;9:e015672. https:\/\/doi.org\/10.1161\/JAHA.119.015672.","journal-title":"J Am Heart Assoc"},{"key":"7950_CR45","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cardfail.2008.07.233","volume":"14","author":"K Naito","year":"2008","unstructured":"Naito K, Anzai T, Yoshikawa T, et al. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling. J Card Fail. 2008;14:831\u20138. https:\/\/doi.org\/10.1016\/j.cardfail.2008.07.233.","journal-title":"J Card Fail"},{"key":"7950_CR46","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1021\/acs.nanolett.8b02578","volume":"18","author":"T Bejerano","year":"2018","unstructured":"Bejerano T, Etzion S, Elyagon S, Etzion Y, Cohen S. Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction. Nano Lett. 2018;18:5885\u201391. https:\/\/doi.org\/10.1021\/acs.nanolett.8b02578.","journal-title":"Nano Lett"},{"key":"7950_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nnano.2012.212","volume":"8","author":"A Parodi","year":"2013","unstructured":"Parodi A, Quattrocchi N, van de Ven AL, et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol. 2013;8:61\u20138. https:\/\/doi.org\/10.1038\/nnano.2012.212.","journal-title":"Nat Nanotechnol"},{"key":"7950_CR48","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jconrel.2012.06.035","volume":"162","author":"LE Paulis","year":"2012","unstructured":"Paulis LE, Geelen T, Kuhlmann MT, et al. Distribution of lipid-based nanoparticles to infarcted myocardium for MRI-monitored drug delivery. J Control Release. 2012;162:276\u201385. https:\/\/doi.org\/10.1016\/j.jconrel.2012.06.035.","journal-title":"J Control Release"},{"key":"7950_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/eurheartj\/ehw240","volume":"38","author":"R Gallet","year":"2017","unstructured":"Gallet R, Dawkins J, Valle J, et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J. 2017;38:201\u201311. https:\/\/doi.org\/10.1093\/eurheartj\/ehw240.","journal-title":"Eur Heart J"},{"key":"7950_CR50","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41467-025-58260-0","volume":"16","author":"S Fu","year":"2025","unstructured":"Fu S, Wang Z, Huang P, et al. Programmable production of bioactive extracellular vesicles in vivo to treat myocardial infarction. Nat Commun. 2025;16:2924. https:\/\/doi.org\/10.1038\/s41467-025-58260-0.","journal-title":"Nat Commun"},{"key":"7950_CR51","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1021\/acsami.8b20158","volume":"11","author":"W Wang","year":"2019","unstructured":"Wang W, Chen J, Li M, et al. Rebuilding postinfarcted cardiac functions by injecting TIIA@PDA nanoparticle-cross-linked ROS-sensitive hydrogels. ACS Appl Mater Interfaces. 2019;11:2880\u201390. https:\/\/doi.org\/10.1021\/acsami.8b20158.","journal-title":"ACS Appl Mater Interfaces"},{"key":"7950_CR52","doi-asserted-by":"publisher","first-page":"7826","DOI":"10.1021\/acsnano.8b01977","volume":"12","author":"E Mihalko","year":"2018","unstructured":"Mihalko E, Huang K, Sproul E, Cheng K, Brown AC. Targeted treatment of ischemic and fibrotic complications of myocardial infarction using a dual-delivery microgel therapeutic. ACS Nano. 2018;12:7826\u201337. https:\/\/doi.org\/10.1021\/acsnano.8b01977.","journal-title":"ACS Nano"},{"key":"7950_CR53","doi-asserted-by":"publisher","first-page":"9738","DOI":"10.1021\/acsnano.7b01008","volume":"11","author":"J Tang","year":"2017","unstructured":"Tang J, Cui X, Caranasos TG, et al. Heart repair using nanogel-encapsulated human cardiac stem cells in mice and pigs with myocardial infarction. ACS Nano. 2017;11:9738\u201349. https:\/\/doi.org\/10.1021\/acsnano.7b01008.","journal-title":"ACS Nano"},{"key":"7950_CR54","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.biomaterials.2017.11.012","volume":"155","author":"A Ottersbach","year":"2018","unstructured":"Ottersbach A, Mykhaylyk O, Heidsieck A, et al. Improved heart repair upon myocardial infarction: combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytes. Biomaterials. 2018;155:176\u201390. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.11.012.","journal-title":"Biomaterials"},{"key":"7950_CR55","doi-asserted-by":"publisher","first-page":"18544","DOI":"10.1002\/jcp.28492","volume":"234","author":"BF Zhang","year":"2019","unstructured":"Zhang BF, Jiang H, Chen J, Hu Q, Yang S, Liu XP. Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction. J Cell Physiol. 2019;234:18544\u201359. https:\/\/doi.org\/10.1002\/jcp.28492.","journal-title":"J Cell Physiol"},{"key":"7950_CR56","doi-asserted-by":"publisher","first-page":"eaan6205","DOI":"10.1126\/scitranslmed.aan6205","volume":"10","author":"M Miragoli","year":"2018","unstructured":"Miragoli M, Ceriotti P, Iafisco M, et al. Inhalation of peptide-loaded nanoparticles improves heart failure. Sci Transl Med. 2018;10:eaan6205. https:\/\/doi.org\/10.1126\/scitranslmed.aan6205.","journal-title":"Sci Transl Med"},{"key":"7950_CR57","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404. https:\/\/doi.org\/10.1002\/jev2.12404.","journal-title":"J Extracell Vesicles"},{"key":"7950_CR58","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","volume":"13","author":"M Faria","year":"2018","unstructured":"Faria M, Bj\u00f6rnmalm M, Thurecht KJ, et al. Minimum information reporting in bio\u2013nano experimental literature. Nat Nanotechnol. 2018;13:777\u201385. https:\/\/doi.org\/10.1038\/s41565-018-0246-4.","journal-title":"Nat Nanotechnol"},{"key":"7950_CR59","volume-title":"Drug products, including biological products, that contain nanomaterials: guidance for industry","author":"U.S. Food and Drug Administration","year":"2022","unstructured":"U.S. Food and Drug Administration. Drug products, including biological products, that contain nanomaterials: guidance for industry. Silver Spring: U.S. Food and Drug Administration; 2022. https:\/\/www.fda.gov\/media\/157812\/download. Accessed 20 August 2026."},{"key":"7950_CR60","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1021\/nn2048069","volume":"6","author":"F Pagliari","year":"2012","unstructured":"Pagliari F, Mandoli C, Forte G, et al. Cerium oxide nanoparticles protect cardiac progenitor cells from oxidative stress. ACS Nano. 2012;6:3767\u201375. https:\/\/doi.org\/10.1021\/nn2048069.","journal-title":"ACS Nano"},{"key":"7950_CR61","doi-asserted-by":"publisher","first-page":"30631","DOI":"10.1021\/acsami.9b10645","volume":"11","author":"M Zhang","year":"2019","unstructured":"Zhang M, Zhu J, Qin X, et al. Cardioprotection of tetrahedral DNA nanostructures in myocardial ischemia-reperfusion injury. ACS Appl Mater Interfaces. 2019;11:30631\u20139. https:\/\/doi.org\/10.1021\/acsami.9b10645.","journal-title":"ACS Appl Mater Interfaces"},{"key":"7950_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.biomaterials.2015.12.022","volume":"83","author":"I Somasuntharam","year":"2016","unstructured":"Somasuntharam I, Yehl K, Carroll SL, et al. Knockdown of TNF-alpha by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction. Biomaterials. 2016;83:12\u201322. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.12.022.","journal-title":"Biomaterials"},{"key":"7950_CR63","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/cvr\/cvz066","volume":"115","author":"M Fujiwara","year":"2019","unstructured":"Fujiwara M, Matoba T, Koga JI, et al. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice. Cardiovasc Res. 2019;115:1244\u201355. https:\/\/doi.org\/10.1093\/cvr\/cvz066.","journal-title":"Cardiovasc Res"},{"key":"7950_CR64","doi-asserted-by":"publisher","first-page":"342ra80","DOI":"10.1126\/scitranslmed.aaf1435","volume":"8","author":"HB Sager","year":"2016","unstructured":"Sager HB, Dutta P, Dahlman JE, et al. RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction. Sci Transl Med. 2016;8:342ra80. https:\/\/doi.org\/10.1126\/scitranslmed.aaf1435.","journal-title":"Sci Transl Med"},{"key":"7950_CR65","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/cvr\/cvu167","volume":"103","author":"L Barile","year":"2014","unstructured":"Barile L, Lionetti V, Cervio E, et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res. 2014;103:530\u201341. https:\/\/doi.org\/10.1093\/cvr\/cvu167.","journal-title":"Cardiovasc Res"},{"key":"7950_CR66","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1318","volume":"12","author":"L Gao","year":"2020","unstructured":"Gao L, Wang L, Wei Y, et al. Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine. Sci Transl Med. 2020;12:eaay1318. https:\/\/doi.org\/10.1126\/scitranslmed.aay1318.","journal-title":"Sci Transl Med"},{"key":"7950_CR67","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/CIRCRESAHA.117.311769","volume":"122","author":"M Adamiak","year":"2018","unstructured":"Adamiak M, Cheng G, Bobis-Wozowicz S, et al. Induced pluripotent stem cell-derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs. Circ Res. 2018;122:296\u2013309. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311769.","journal-title":"Circ Res"},{"key":"7950_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121529","volume":"284","author":"Q Li","year":"2022","unstructured":"Li Q, Huang Z, Wang Q, et al. Targeted immunomodulation therapy for cardiac repair by platelet membrane engineering extracellular vesicles via hitching peripheral monocytes. Biomaterials. 2022;284:121529. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121529.","journal-title":"Biomaterials"},{"key":"7950_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121000","volume":"275","author":"Z Wei","year":"2021","unstructured":"Wei Z, Chen Z, Zhao Y, et al. Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. Biomaterials. 2021;275:121000. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121000.","journal-title":"Biomaterials"},{"key":"7950_CR70","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.116.024590","volume":"136","author":"G de Couto","year":"2017","unstructured":"de Couto G, Gallet R, Cambier L, et al. Exosomal microRNA transfer into macrophages mediates cellular postconditioning. Circulation. 2017;136:200\u201314. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024590.","journal-title":"Circulation"},{"key":"7950_CR71","doi-asserted-by":"publisher","first-page":"337","DOI":"10.15252\/emmm.201606924","volume":"9","author":"L Cambier","year":"2017","unstructured":"Cambier L, de Couto G, Ibrahim A, et al. Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion. EMBO Mol Med. 2017;9:337\u201352. https:\/\/doi.org\/10.15252\/emmm.201606924.","journal-title":"EMBO Mol Med"},{"key":"7950_CR72","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/cvr\/cvaa028","volume":"117","author":"B Lima Correa","year":"2021","unstructured":"Lima Correa B, El Harane N, Gomez I, et al. Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts. Cardiovasc Res. 2021;117:292\u2013307. https:\/\/doi.org\/10.1093\/cvr\/cvaa028.","journal-title":"Cardiovasc Res"},{"key":"7950_CR73","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/cvr\/cvz040","volume":"115","author":"J Zhao","year":"2019","unstructured":"Zhao J, Li X, Hu J, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 2019;115:1205\u201316. https:\/\/doi.org\/10.1093\/cvr\/cvz040.","journal-title":"Cardiovasc Res"},{"key":"7950_CR74","doi-asserted-by":"publisher","first-page":"12750","DOI":"10.1111\/jcmm.15860","volume":"24","author":"Y Wang","year":"2020","unstructured":"Wang Y, Han B, Wang Y, et al. Mesenchymal stem cell-secreted extracellular vesicles carrying TGF-beta1 up-regulate miR-132 and promote mouse M2 macrophage polarization. J Cell Mol Med. 2020;24:12750\u201364. https:\/\/doi.org\/10.1111\/jcmm.15860.","journal-title":"J Cell Mol Med"},{"key":"7950_CR75","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.1111\/jcmm.14635","volume":"23","author":"R Xu","year":"2019","unstructured":"Xu R, Zhang F, Chai R, et al. Exosomes derived from pro-inflammatory bone marrow-derived mesenchymal stem cells reduce inflammation and myocardial injury via mediating macrophage polarization. J Cell Mol Med. 2019;23:7617\u201331. https:\/\/doi.org\/10.1111\/jcmm.14635.","journal-title":"J Cell Mol Med"},{"key":"7950_CR76","doi-asserted-by":"publisher","first-page":"105564","DOI":"10.1016\/j.biocel.2019.105564","volume":"114","author":"S Deng","year":"2019","unstructured":"Deng S, Zhou X, Ge Z, et al. Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P\/SK1\/S1PR1 signaling and promoting macrophage M2 polarization. Int J Biochem Cell Biol. 2019;114:105564. https:\/\/doi.org\/10.1016\/j.biocel.2019.105564.","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"7950_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.celbio.2025.100152","volume":"1","author":"K Huang","year":"2025","unstructured":"Huang K, Zhu D, Soto J, et al. Immunomodulatory microneedle patch for cardiac repair in rodent and porcine models of myocardial infarction. Cell Biomater. 2025;1(9):100152. https:\/\/doi.org\/10.1016\/j.celbio.2025.100152.","journal-title":"Cell Biomater"},{"key":"7950_CR78","doi-asserted-by":"publisher","first-page":"111734","DOI":"10.1016\/j.compositesb.2024.111734","volume":"285","author":"Z Wang","year":"2024","unstructured":"Wang Z, Hu C, Zhang W, et al. Dynamically crosslinked ECM-like hydrogels loaded with ROS-responsive drug nanoparticles for treating inflammation in myocardial infarction and stroke. Compos Part B Eng. 2024;285:111734. https:\/\/doi.org\/10.1016\/j.compositesb.2024.111734.","journal-title":"Compos Part B Eng"},{"key":"7950_CR79","doi-asserted-by":"publisher","first-page":"1801570","DOI":"10.1002\/adma.201801570","volume":"30","author":"JJ Nie","year":"2018","unstructured":"Nie JJ, Qiao B, Duan S, et al. Unlockable nanocomplexes with self-accelerating nucleic acid release for effective staged gene therapy of cardiovascular diseases. Adv Mater. 2018;30:1801570. https:\/\/doi.org\/10.1002\/adma.201801570.","journal-title":"Adv Mater"},{"key":"7950_CR80","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1021\/acsnano.2c10042","volume":"17","author":"X Ji","year":"2023","unstructured":"Ji X, Meng Y, Wang Q, et al. Cysteine-based redox-responsive nanoparticles for fibroblast-targeted drug delivery in the treatment of myocardial infarction. ACS Nano. 2023;17:5421\u201334. https:\/\/doi.org\/10.1021\/acsnano.2c10042.","journal-title":"ACS Nano"},{"key":"7950_CR81","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","volume":"343","author":"MJW Evers","year":"2022","unstructured":"Evers MJW, Du W, Yang Q, et al. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles. J Control Release. 2022;343:207\u201316. https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.027.","journal-title":"J Control Release"},{"key":"7950_CR82","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jconrel.2024.04.018","volume":"369","author":"MCI Labonia","year":"2024","unstructured":"Labonia MCI, Estap\u00e9 Senti M, van der Kraak PH, et al. Cardiac delivery of modified mRNA using lipid nanoparticles: cellular targets and biodistribution after intramyocardial administration. J Control Release. 2024;369:734\u201345. https:\/\/doi.org\/10.1016\/j.jconrel.2024.04.018.","journal-title":"J Control Release"},{"key":"7950_CR83","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik JG, Tomb\u00e1cz I, Yadegari A, et al. CAR T cells produced in vivo to treat cardiac injury. Science. 2022;375:91\u20136. https:\/\/doi.org\/10.1126\/science.abm0594.","journal-title":"Science"},{"issue":"6","key":"7950_CR84","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/CIRCRESAHA.125.326716","volume":"137","author":"H Du","year":"2025","unstructured":"Du H, You X, Zhang J, et al. CAR macrophages engineered in vivo for attenuating myocardial ischemia\u2013reperfusion injury. Circ Res. 2025;137(6):846\u201359. https:\/\/doi.org\/10.1161\/CIRCRESAHA.125.326716.","journal-title":"Circ Res"},{"key":"7950_CR85","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijcard.2015.05.020","volume":"192","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhang L, Li Y, et al. Exosomes\/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol. 2015;192:61\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.020.","journal-title":"Int J Cardiol"},{"key":"7950_CR86","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/stem.2078","volume":"33","author":"S Bobis-Wozowicz","year":"2015","unstructured":"Bobis-Wozowicz S, Kmiotek K, Sekula M, et al. Human induced pluripotent stem cell-derived microvesicles transmit RNAs and proteins to recipient mature heart cells modulating cell fate and behavior. Stem Cells. 2015;33:2748\u201361. https:\/\/doi.org\/10.1002\/stem.2078.","journal-title":"Stem Cells"},{"key":"7950_CR87","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvz139","volume":"116","author":"P Huang","year":"2020","unstructured":"Huang P, Wang L, Li Q, et al. Atorvastatin enhances therapeutic efficacy of mesenchymal stem cell-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020;116:353\u201367. https:\/\/doi.org\/10.1093\/cvr\/cvz139.","journal-title":"Cardiovasc Res"},{"key":"7950_CR88","doi-asserted-by":"publisher","first-page":"13878","DOI":"10.1002\/jcp.28070","volume":"234","author":"XH Gong","year":"2019","unstructured":"Gong XH, Liu H, Wang SJ, Liang SW, Wang GG. Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction. J Cell Physiol. 2019;234:13878\u201393. https:\/\/doi.org\/10.1002\/jcp.28070.","journal-title":"J Cell Physiol"},{"key":"7950_CR89","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.7150\/thno.28021","volume":"8","author":"LP Zhu","year":"2018","unstructured":"Zhu LP, Tian T, Wang JY, et al. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitate cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction. Theranostics. 2018;8:6163\u201377. https:\/\/doi.org\/10.7150\/thno.28021.","journal-title":"Theranostics"},{"key":"7950_CR90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fcell.2020.00011","volume":"8","author":"W Xuan","year":"2020","unstructured":"Xuan W, Khan M, Ashraf M. Extracellular vesicles from Notch activated cardiac mesenchymal stem cells promote myocyte proliferation and angiogenesis. Front Cell Dev Biol. 2020;8:11. https:\/\/doi.org\/10.3389\/fcell.2020.00011.","journal-title":"Front Cell Dev Biol"},{"key":"7950_CR91","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3290372","author":"T Ma","year":"2018","unstructured":"Ma T, Chen Y, Chen Y, et al. MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promotes angiogenesis in myocardial infarction. Stem Cells Int. 2018. https:\/\/doi.org\/10.1155\/2018\/3290372.","journal-title":"Stem Cells Int"},{"key":"7950_CR92","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.thromres.2019.02.002","volume":"177","author":"XH Sun","year":"2019","unstructured":"Sun XH, Wang X, Zhang Y, Hui J. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486\u20135p targeting the PTEN\/PI3K\/AKT signaling pathway. Thromb Res. 2019;177:23\u201332. https:\/\/doi.org\/10.1016\/j.thromres.2019.02.002.","journal-title":"Thromb Res"},{"key":"7950_CR93","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.omtn.2018.01.010","volume":"11","author":"J Liu","year":"2018","unstructured":"Liu J, Jiang M, Deng S, et al. miR-93\u20135p-containing exosomes treatment attenuates acute myocardial infarction-induced myocardial damage. Mol Ther Nucleic Acids. 2018;11:103\u201315. https:\/\/doi.org\/10.1016\/j.omtn.2018.01.010.","journal-title":"Mol Ther Nucleic Acids"},{"key":"7950_CR94","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.7150\/thno.29945","volume":"9","author":"Y Song","year":"2019","unstructured":"Song Y, Zhang C, Zhang J, et al. Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction. Theranostics. 2019;9:2346\u201360. https:\/\/doi.org\/10.7150\/thno.29945.","journal-title":"Theranostics"},{"key":"7950_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8010018","volume":"8","author":"SW Youn","year":"2019","unstructured":"Youn SW, Li Y, Kim YM, et al. Modification of cardiac progenitor cell-derived exosomes by miR-322 provides protection against myocardial infarction through NOX2-dependent angiogenesis. Antioxidants (Basel). 2019;8:18. https:\/\/doi.org\/10.3390\/antiox8010018.","journal-title":"Antioxidants (Basel)"},{"key":"7950_CR96","doi-asserted-by":"publisher","first-page":"107389","DOI":"10.1016\/j.intimp.2021.107389","volume":"93","author":"Z Wu","year":"2021","unstructured":"Wu Z, Cheng S, Wang S, Li W, Liu J. BMSCs-derived exosomal microRNA-150\u20135p attenuates myocardial infarction in mice. Int Immunopharmacol. 2021;93:107389. https:\/\/doi.org\/10.1016\/j.intimp.2021.107389.","journal-title":"Int Immunopharmacol"},{"key":"7950_CR97","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2217\/rme-2019-0136","volume":"15","author":"S Wang","year":"2020","unstructured":"Wang S, Li L, Liu T, Jiang W, Hu X. miR-19a\/19b-loaded exosomes in combination with mesenchymal stem cell transplantation in a preclinical model of myocardial infarction. Regen Med. 2020;15:1749\u201359. https:\/\/doi.org\/10.2217\/rme-2019-0136.","journal-title":"Regen Med"},{"key":"7950_CR98","doi-asserted-by":"publisher","first-page":"569150","DOI":"10.3389\/fcell.2020.569150","volume":"8","author":"TC Lai","year":"2020","unstructured":"Lai TC, Lee TL, Chang YC, et al. MicroRNA-221\/222 mediates ADSC-exosome-induced cardioprotection against ischemia\/reperfusion by targeting PUMA and ETS-1. Front Cell Dev Biol. 2020;8:569150. https:\/\/doi.org\/10.3389\/fcell.2020.569150.","journal-title":"Front Cell Dev Biol"},{"key":"7950_CR99","doi-asserted-by":"publisher","first-page":"1958941","DOI":"10.1155\/2019\/1958941","volume":"2019","author":"J Ni","year":"2019","unstructured":"Ni J, Liu X, Yin Y, Zhang P, Xu YW, Liu Z. Exosomes derived from TIMP2-modified human umbilical cord mesenchymal stem cells enhance repair in a rat model of myocardial infarction possibly by the Akt\/Sfrp2 pathway. Oxid Med Cell Longev. 2019;2019:1958941. https:\/\/doi.org\/10.1155\/2019\/1958941.","journal-title":"Oxid Med Cell Longev"},{"key":"7950_CR100","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/FJC.0000000000000507","volume":"70","author":"X Cui","year":"2017","unstructured":"Cui X, He Z, Liang Z, Chen Z, Wang H, Zhang J. Exosomes from adipose-derived mesenchymal stem cells protect the myocardium against ischemia\/reperfusion injury through Wnt\/beta-catenin signaling. J Cardiovasc Pharmacol. 2017;70:225\u201331. https:\/\/doi.org\/10.1097\/FJC.0000000000000507.","journal-title":"J Cardiovasc Pharmacol"},{"key":"7950_CR101","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1002\/adhm.201600308","volume":"5","author":"KR Vrijsen","year":"2016","unstructured":"Vrijsen KR, Maring JA, Chamuleau SAJ, et al. Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis via EMMPRIN. Adv Healthc Mater. 2016;5:2555\u201365. https:\/\/doi.org\/10.1002\/adhm.201600308.","journal-title":"Adv Healthc Mater"},{"issue":"10","key":"7950_CR102","doi-asserted-by":"publisher","first-page":"e70178","DOI":"10.1002\/jev2.70178","volume":"14","author":"W Wang","year":"2025","unstructured":"Wang W, Han Z, Aafreen S, et al. Magnetically labelled iPSC-derived extracellular vesicles enable MRI\/MPI-guided regenerative therapy for myocardial infarction. J Extracell Vesicles. 2025;14(10):e70178. https:\/\/doi.org\/10.1002\/jev2.70178.","journal-title":"J Extracell Vesicles"},{"key":"7950_CR103","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41551-020-00637-1","volume":"4","author":"S Liu","year":"2020","unstructured":"Liu S, Chen X, Bao L, et al. Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles. Nat Biomed Eng. 2020;4:1063\u201375. https:\/\/doi.org\/10.1038\/s41551-020-00637-1.","journal-title":"Nat Biomed Eng"},{"key":"7950_CR104","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3389\/fphys.2018.01169","volume":"9","author":"G Andriolo","year":"2018","unstructured":"Andriolo G, Provasi E, Lo Cicero V, et al. Exosomes from human cardiac progenitor cells for therapeutic applications: development of a GMP-grade manufacturing method. Front Physiol. 2018;9:1169. https:\/\/doi.org\/10.3389\/fphys.2018.01169.","journal-title":"Front Physiol"},{"key":"7950_CR105","doi-asserted-by":"publisher","first-page":"eaaz0952","DOI":"10.1126\/sciadv.aaz0952","volume":"6","author":"JR Lee","year":"2020","unstructured":"Lee JR, Park BW, Kim J, et al. Nanovesicles derived from iron oxide nanoparticles-incorporated mesenchymal stem cells for cardiac repair. Sci Adv. 2020;6:eaaz0952. https:\/\/doi.org\/10.1126\/sciadv.aaz0952.","journal-title":"Sci Adv"},{"key":"7950_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113989","volume":"385","author":"C Huang","year":"2025","unstructured":"Huang C, Chng WH, Neupane YR, et al. Adipose stem cell-derived nanovesicles for cardioprotection: production and identification of therapeutic components. J Control Release. 2025;385:113989. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113989.","journal-title":"J Control Release"},{"key":"7950_CR107","unstructured":"ClinicalTrials.gov. Safety evaluation of intracoronary infusion of extracellular vesicles in patients following coronary stent implantation. Identifier NCT04327635. https:\/\/clinicaltrials.gov\/study\/NCT04327635. Accessed 20 August 2026."},{"key":"7950_CR108","unstructured":"ClinicalTrials.gov. Co-transplantation of mesenchymal stem cell-derived exosomes and autologous mitochondria for patients undergoing coronary artery bypass grafting. Identifier NCT05669144. https:\/\/clinicaltrials.gov\/study\/NCT05669144. Accessed 20 August 2026."},{"key":"7950_CR109","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.ijcha.2025.101771","volume":"60","author":"AG Ferrari","year":"2025","unstructured":"Ferrari AG, Maranh\u00e3o RC, Salsoso R, et al. Effect of intravenous methotrexate carried by lipid nanoemulsion in patients with anterior ST-elevation myocardial infarction. Int J Cardiol Heart Vasc. 2025;60:101771. https:\/\/doi.org\/10.1016\/j.ijcha.2025.101771.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"7950_CR110","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12951-022-01445-2","volume":"20","author":"F Li","year":"2022","unstructured":"Li F, Liu D, Liu M, et al. Tregs biomimetic nanoparticle to reprogram inflammatory and redox microenvironment in infarct tissue to treat myocardial ischemia reperfusion injury in mice. J Nanobiotechnol. 2022;20:251. https:\/\/doi.org\/10.1186\/s12951-022-01445-2.","journal-title":"J Nanobiotechnol"},{"key":"7950_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120256","volume":"257","author":"C Yao","year":"2020","unstructured":"Yao C, Wu W, Tang H, et al. Self-assembly of stem cell membrane-camouflaged nanocomplex for microRNA-mediated repair of myocardial infarction injury. Biomaterials. 2020;257:120256. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120256.","journal-title":"Biomaterials"},{"key":"7950_CR112","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/stem.2777","volume":"36","author":"Q Ma","year":"2018","unstructured":"Ma Q, Yang J, Huang X, et al. Poly(lactide-co-glycolide)-monomethoxy-poly(polyethylene glycol) nanoparticles loaded with melatonin protect adipose-derived stem cells transplanted in infarcted heart tissue. Stem Cells. 2018;36:540\u201350. https:\/\/doi.org\/10.1002\/stem.2777.","journal-title":"Stem Cells"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07950-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07950-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07950-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:02:58Z","timestamp":1788634978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-026-07950-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":112,"alternative-id":["7950"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07950-y","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"21 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During preparation of this manuscript, the authors used OpenAI ChatGPT to assist with language editing. The authors reviewed, verified, and revised all content and take full responsibility for the final manuscript.","order":4,"name":"Ethics","label":"Use of Artificial Intelligence","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}